Targeting mTOR and Src restricts hepatocellular carcinoma growth in a novel murine liver cancer model

Sarah Walker1,2, Miriam Wankell3, Vikki Ho1

  • 1Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Westmead, Australia.

Plos One
|February 23, 2019
PubMed

Insights

Adiponectin deficiency exacerbates liver cancer (hepatocellular carcinoma) growth. Combining mTOR and Src inhibitors significantly reduced tumor growth, suggesting a novel therapeutic strategy for hepatocellular carcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Hepatocellular carcinoma (HCC) presents a poor prognosis with limited therapeutic options.
  • Adiponectin (APN) plays a role in regulating cell growth and metabolism.
  • Investigating the role of APN in HCC development and identifying novel therapeutic targets is crucial.

Purpose of the Study:

  • To investigate the impact of adiponectin deficiency on hepatocellular carcinoma (HCC) development and progression.
  • To identify potential therapeutic targets for HCC by analyzing activated signaling pathways.
  • To evaluate the efficacy of combined inhibition of mTOR and Src pathways in HCC treatment.

Main Methods:

  • Generated hepatocellular carcinoma (HCC) cells from adiponectin (APN) knock-out and wild-type murine models.
  • Administered carcinogen diethylnitrosamine to induce tumors.
  • Evaluated tumor growth characteristics in vitro and in vivo.
  • Assessed the activity of mammalian target of Rapamycin (mTOR) and Src pathways.
  • Conducted combinatorial treatment with mTOR inhibitor Rapamycin and Src inhibitor Dasatinib.

Main Results:

  • Adiponectin knock-out mice developed significantly larger tumors (7-fold) compared to wild-type controls.
  • Derived A52 HCC cells from APN KO mice exhibited robust in vitro and in vivo growth with similar pathology to parental tumors.
  • Both primary tumors and cell lines showed activation of mammalian target of Rapamycin (mTOR) and Src pathways.
  • Combined treatment with Rapamycin and Dasatinib reduced A52 HCC growth by 29-fold in vivo.
  • Protein and histological analyses confirmed mTOR and Src pathway activation in human HCC samples.

Conclusions:

  • Adiponectin deficiency promotes hepatocellular carcinoma (HCC) growth.
  • The mammalian target of Rapamycin (mTOR) and Src pathways are activated in HCC.
  • Combined inhibition of mTOR and Src represents a promising novel therapeutic strategy for treating HCC.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Restriction Enzymes01:11

Restriction Enzymes

Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
36.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.5K
Growth Models with Integration: Problem Solving01:27

Growth Models with Integration: Problem Solving

In population modeling, integration provides a systematic way to determine accumulated quantities from known rates of change. One such application arises in ecology, where the total weight of a fish population in a body of water is referred to as its biomass. When the rate of growth of this biomass is known as a function of time, calculus can be used to determine the total biomass at a future date.Growth Rate and Biomass FunctionLet the growth rate of the fish population be represented by a...
55
Exponential Equations for Modeling Growth02:33

Exponential Equations for Modeling Growth

Exponential models are essential for describing rapid, multiplicative changes in natural systems, such as population growth. When a population doubles at regular intervals, the process can be modeled using a suitable base. For instance, a bacterial culture that doubles every three hours follows the model n(t)=n0⋅2t/3, where n(t) is the population at the time t.A more general model uses the natural base e, especially for continuous growth. This takes the form n(t)=n0⋅ert, where r is...
242